This topic contains a solution. Click here to go to the answer

Author Question: Which drug does the nurse prepare to administer to a patient receiving combination chemothe-rapy who ... (Read 48 times)

ec501234

  • Hero Member
  • *****
  • Posts: 573
Which drug does the nurse prepare to administer to a patient receiving combination chemothe-rapy who has a red blood cell (RBC) count of 120 million/mm3?
 
  a. Bleomycin (Blenoxane)
  b. Oprelvekin (Neumega)
  c. Epoetin alfa (Procrit)
  d. Megestrol (Megace)

Question 2

A patient arrives to receive a second round of combination chemotherapy. What is the most important patient assessment finding for the nurse to report to the prescriber?
 
  a. Height
  b. Weight
  c. Blood pressure
  d. Pulse rate and rhythm



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

l.stuut

  • Sr. Member
  • ****
  • Posts: 345
Answer to Question 1

C
The RBC count is low and the patient is anemic. Epoetin alfa is a biological response modifier that increases bone marrow production of RBCs and reduces the severity of anemia. The other drugs are chemotherapy agents (bleomycin), hormones (megestrol), and a biological response modifier that affects platelets rather than RBCs (oprelvekin Neumega).

Answer to Question 2

B
Many intravenous chemotherapy drugs are dosed based on the patient's meter square (m2) of to-tal body surface area. This measurement is calculated from the patient's height in centimeters and weight in kilograms. The patient's weight can change drastically from one round of chemo-therapy to the next. Height does not change. Because this is the patient's second round, an accu-rate weight is needed to calculate the correct drug dosages.



ec501234

  • Hero Member
  • *****
  • Posts: 573
Both answers were spot on, thank you once again




 

Did you know?

The first documented use of surgical anesthesia in the United States was in Connecticut in 1844.

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

Approximately 25% of all reported medication errors result from some kind of name confusion.

Did you know?

Approximately 500,000 babies are born each year in the United States to teenage mothers.

Did you know?

This year, an estimated 1.4 million Americans will have a new or recurrent heart attack.

For a complete list of videos, visit our video library